Msn Laboratories
Msn Laboratories, officially known as Msn Laboratories Pvt. Ltd., is a prominent player in the pharmaceutical industry, headquartered in India. Established in 2003, the company has rapidly expanded its operations across major regions, including Europe, the Americas, and Asia, solidifying its position in the global market. Specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, Msn Laboratories is recognised for its commitment to quality and innovation. The company’s core products include a diverse range of therapeutic solutions, particularly in the fields of oncology, cardiology, and anti-infectives, setting it apart with its robust research and development capabilities. With a strong market presence, Msn Laboratories has achieved several milestones, including regulatory approvals from major health authorities, which underscores its dedication to excellence and reliability in the pharmaceutical sector.
DitchCarbon Score
How does Msn Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Msn Laboratories's score of 24 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Msn Laboratories's reported carbon emissions
In 2024, Msn Laboratories reported total carbon emissions of approximately 126,073,600 kg CO2e for Scope 1 and about 135,767,630 kg CO2e for Scope 2. Additionally, Scope 3 emissions were recorded at around 66,735,710 kg CO2e, which includes significant contributions from purchased goods and services (approximately 12,726,040 kg CO2e) and fuel and energy-related activities (about 42,445,000 kg CO2e). Msn Laboratories is committed to achieving net zero emissions by 2045, a goal that underpins their strategic initiatives and operational improvements. This long-term commitment encompasses all scopes of emissions, reflecting a comprehensive approach to climate action. The company has consistently reported emissions data, with 2023 figures showing Scope 1 emissions at approximately 83,016,740 kg CO2e and Scope 2 emissions at about 109,040,650 kg CO2e. The emissions data for 2022 mirrored these figures, indicating a stable emissions profile in recent years. Msn Laboratories operates independently, with no emissions data cascaded from a parent company, ensuring that their climate commitments and performance are solely reflective of their own operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 83,016,740 | 00,000,000 | 000,000,000 |
| Scope 2 | 109,040,650 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Msn Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
